Glucagon-like peptide-1 receptor agonists, known as GLP-1s, are a class of prescription drugs used to help people with Type 2 diabetes manage their blood sugar levels and reduce their chances of stroke and heart attack, according to a study from Frontiers in Clinical Diabetes and Healthcare
These can include nausea, constipation, diarrhea, reflux, bloating, decreased appetite, abdominal discomfort, or vomiting
Lipo injections pose very few health and safety concerns, with mild side effects including headache, fatigue, nausea, and discomfort at the injection site
This makes it difficult to draw firm conclusions
1986 Sep;7(9):1463-6